Every report the desk has filed, searchable by full text, topic, format, symbol and date range.
Investors demanded firmer sales targets and got an admission from the CEO that the drug pipeline is the company's main problem.
Novo Nordisk's stock fell sharply after its CEO conceded the pipeline is the company's central weakness and investors pushed back on the sales targets management offered.
A heavy slate of target revisions from Guggenheim, Canaccord and UBS spans oncology, energy and household products, even as a 20% collapse in Chinese passenger vehicle retail sales flags a genuine demand shock in the world's largest auto market.
Sell-side research activity clustered in clinical-stage biotech and consumer discretionary names, with upgrades for ConocoPhillips, SharkNinja, BridgeBio and Cogent offset by reductions at Middleby and Neurogene. The sharper signal came from China, where July passenger vehicle retail sales fell 20% year over year.